These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 20727784)
21. Effects of MSC coadministration and route of delivery on cord blood hematopoietic stem cell engraftment. Carrancio S; Romo C; Ramos T; Lopez-Holgado N; Muntion S; Prins HJ; Martens AC; Briñón JG; San Miguel JF; Del Cañizo MC; Sanchez-Guijo F Cell Transplant; 2013; 22(7):1171-83. PubMed ID: 23031585 [TBL] [Abstract][Full Text] [Related]
22. Immunotherapy after hematopoietic stem cell transplantation using umbilical cord blood-derived products. Saudemont A; Madrigal JA Cancer Immunol Immunother; 2017 Feb; 66(2):215-221. PubMed ID: 27271550 [TBL] [Abstract][Full Text] [Related]
23. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Barker JN; Davies SM; DeFor T; Ramsay NK; Weisdorf DJ; Wagner JE Blood; 2001 May; 97(10):2957-61. PubMed ID: 11342417 [TBL] [Abstract][Full Text] [Related]
29. Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34 Bucar S; Branco ADM; Mata MF; Milhano JC; Caramalho Í; Cabral JMS; Fernandes-Platzgummer A; da Silva CL Stem Cell Res Ther; 2021 Jul; 12(1):399. PubMed ID: 34256848 [TBL] [Abstract][Full Text] [Related]
30. [A comparison between immunophenotypes of lymphoid cells from human umbilical cord blood and bone marrow and its significance]. Guo R; Zou P; Zou DB Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Dec; 10(6):519-22. PubMed ID: 12513712 [TBL] [Abstract][Full Text] [Related]
31. Hematopoietic stem-cell transplantation using unrelated cord-blood versus matched sibling marrow in pediatric bone marrow failure syndrome: one center's experience. Shaw PH; Haut PR; Olszewski M; Kletzel M Pediatr Transplant; 1999 Nov; 3(4):315-21. PubMed ID: 10562977 [TBL] [Abstract][Full Text] [Related]
32. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation. Tian Y; Deng YB; Huang YJ; Wang Y Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798 [TBL] [Abstract][Full Text] [Related]
33. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit. Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548 [TBL] [Abstract][Full Text] [Related]
34. Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse Model. Escobedo-Cousin M; Jackson N; Laza-Briviesca R; Ariza-McNaughton L; Luevano M; Derniame S; Querol S; Blundell M; Thrasher A; Soria B; Cooper N; Bonnet D; Madrigal A; Saudemont A PLoS One; 2015; 10(10):e0138623. PubMed ID: 26465138 [TBL] [Abstract][Full Text] [Related]
35. The characteristics of umbilical cord blood (UCB) and UCB transplantation. Kasai M; Masauzi N Semin Thromb Hemost; 1998; 24(5):491-5. PubMed ID: 9834019 [TBL] [Abstract][Full Text] [Related]
36. Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation. Hexner EO; Danet-Desnoyers GA; Zhang Y; Frank DM; Riley JL; Levine BL; Porter DL; June CH; Emerson SG Biol Blood Marrow Transplant; 2007 Oct; 13(10):1135-44. PubMed ID: 17889349 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow. De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; Ley P; de Hemptinne D; Stryckmans P Stem Cells; 1995 May; 13(3):281-8. PubMed ID: 7613494 [TBL] [Abstract][Full Text] [Related]
38. Umbilical cord blood transplantation: Still growing and improving. Zhu X; Tang B; Sun Z Stem Cells Transl Med; 2021 Nov; 10 Suppl 2(Suppl 2):S62-S74. PubMed ID: 34724722 [TBL] [Abstract][Full Text] [Related]
39. Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential. Zheng Y; Watanabe N; Nagamura-Inoue T; Igura K; Nagayama H; Tojo A; Tanosaki R; Takaue Y; Okamoto S; Takahashi TA Exp Hematol; 2003 Dec; 31(12):1237-46. PubMed ID: 14662330 [TBL] [Abstract][Full Text] [Related]
40. Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bernardo ME; Ball LM; Cometa AM; Roelofs H; Zecca M; Avanzini MA; Bertaina A; Vinti L; Lankester A; Maccario R; Ringden O; Le Blanc K; Egeler RM; Fibbe WE; Locatelli F Bone Marrow Transplant; 2011 Feb; 46(2):200-7. PubMed ID: 20400983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]